Arthritis
Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
Published in Medical Verdicts and Law Weekly, May 8th, 2008
Trubion Pharmaceuticals Inc. (NASDAQ:TRBN) announced that its collaboration partner Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), has initiated a Phase 1 clinical trial of SBI-087, a next-generation drug candidate for the treatment of rheumatoid arthritis (RA). In collaboration with Trubion, Wyeth Pharmaceuticals is developing SBI-087 and other CD20-directed products. SBI-087 for RA builds on Trubion and Wyeth's clinical experience with Trubion's lead compound, TRU-015, and is based on Trubion's Small Modular ImmunoPharmaceutical (SMIP(TM)) technology.
The Phase 1 SBI-087 dose escalation clinical trial is designed to evaluate the safety, tolerability,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- Adverse Drug Reactions
Herbalife Responds to Spain's Ministry of Health Alert - Ascendant Solutions, Inc.
Ascendant Solutions Announces the Sale of Medicine Man Pharmacies - BioDefense Corporation
Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection - Biologics
Insmed to Present at CBI Follow-On Biologics Conference - BioMed Realty Trust, Inc.
BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock - bioMETRX Inc.
bioMETRX, Inc. Initiates Integration of Personnel and Assets of Sequiam Corp. - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
